Infektion

The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-term Safety and Tolerability of TMC125 Combined With Other Antiretroviral Drugs. Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients</brief_title>
<official_title>A Phase I/IIa Open-Label, Dose Ranging, Parallel, Safety, Tolerability and Efficacy Study of i.m. Administered CHRONVAC-C® in Combination With Electroporation in Chronic HCV Genotype 1 Infected and Treatment Naïve Patients With Low Viral Load
Glycosaminoglycans During Septic Shock - a Temporal Study  

 








©svenskmedicin.se 2009